1. Home
  2. CLDI vs NEHC Comparison

CLDI vs NEHC Comparison

Compare CLDI & NEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • NEHC
  • Stock Information
  • Founded
  • CLDI 2014
  • NEHC 2023
  • Country
  • CLDI United States
  • NEHC United States
  • Employees
  • CLDI N/A
  • NEHC N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • NEHC
  • Sector
  • CLDI Health Care
  • NEHC
  • Exchange
  • CLDI Nasdaq
  • NEHC NYSE
  • Market Cap
  • CLDI 14.0M
  • NEHC 12.6M
  • IPO Year
  • CLDI N/A
  • NEHC N/A
  • Fundamental
  • Price
  • CLDI $0.48
  • NEHC $0.88
  • Analyst Decision
  • CLDI Strong Buy
  • NEHC
  • Analyst Count
  • CLDI 2
  • NEHC 0
  • Target Price
  • CLDI $15.00
  • NEHC N/A
  • AVG Volume (30 Days)
  • CLDI 386.9K
  • NEHC 212.6K
  • Earning Date
  • CLDI 05-13-2025
  • NEHC 01-01-0001
  • Dividend Yield
  • CLDI N/A
  • NEHC N/A
  • EPS Growth
  • CLDI N/A
  • NEHC N/A
  • EPS
  • CLDI N/A
  • NEHC N/A
  • Revenue
  • CLDI N/A
  • NEHC $532,780.00
  • Revenue This Year
  • CLDI N/A
  • NEHC N/A
  • Revenue Next Year
  • CLDI N/A
  • NEHC N/A
  • P/E Ratio
  • CLDI N/A
  • NEHC N/A
  • Revenue Growth
  • CLDI N/A
  • NEHC N/A
  • 52 Week Low
  • CLDI $0.35
  • NEHC $0.68
  • 52 Week High
  • CLDI $4.90
  • NEHC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 38.44
  • NEHC N/A
  • Support Level
  • CLDI $0.41
  • NEHC N/A
  • Resistance Level
  • CLDI $0.45
  • NEHC N/A
  • Average True Range (ATR)
  • CLDI 0.07
  • NEHC 0.00
  • MACD
  • CLDI 0.02
  • NEHC 0.00
  • Stochastic Oscillator
  • CLDI 56.57
  • NEHC 0.00

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About NEHC NEW ERA HELIUM INC

New Era Helium Inc. is an exploration and production company that sources helium produced in association with the production of natural gas reserves in North America. The Company's primary operations include the exploration, development and production of helium, natural gas, oil and natural gas liquids. The Company owns and operates over 137,000 acres in Southeast New Mexico and has over 1.5 billion cubic feet of proved and probable helium reserves. Its producing oil and gas assets and non-producing acreage are located in Chaves County, New Mexico.

Share on Social Networks: